Â
ãã±ã¬ãçã¿ãããã¨ããã°ããã®éãçãã¬ãã§ããªããªãã¾ãããã®ã¨ãã«ãã©ããã¦ãæ°ã«ãªã£ã¦ãã¾ãã®ãçèéã®æ¸å°ã§ãã誰ããåªåãã¦å¾ãçèã失ããããªããã®ã§ãã
Â
ãããããç¾å®ã¯æ®é ·ã§ãã
Â
ãæ®å¿µãªãããçèã®ä¸æ´»åãã£ã¦çèéã¯1æ¥ããã0.5ã0.6%ãçåã¯0.3ã4.2%æ¸å°ãããã¨ã示åããã¦ãã¾ãï¼Wall BT, 2013ï¼ãçèéã¯ãçèã®ãã¨ã§ããçã¿ã³ãã¯è³ªã®åæã¨å解ã®ãã©ã³ã¹ã«ãã£ã¦æ±ºã¾ãã¾ãããçèã®ä¸æ´»åã¯ãã®ãã©ã³ã¹ãå´©ãã¦ãçèéãæ¸å°ããã¦ãã¦ãã¾ãã®ã§ãã
Â
ãã§ã¯ãã±ã¬ã風éªãªã©ã§èº«ä½ãåãããªãã¨ãã«ãå°ãã§ãçèéã®æ¸å°ãé²ããã¨ã¯ã§ããã®ã§ããããï¼
Â
ãä»åã¯ãçèã®ä¸æ´»åã«ãã£ã¦çèéãæ¸å°ããã¡ã«ããºã ã¨ãã®å¯¾å¿çã«ã¤ãã¦ãç¾å¨ã¾ã§ã®ç¥è¦ããç´¹ä»ãã¾ãã
Â
Table of contents
- â çèã®ä¸æ´»åã¯çã¿ã³ãã¯è³ªã®åææµææ§ãèªçºãã
- â çã¿ã³ãã¯è³ªã®åææµææ§ã®æ¹åã«ã¯ã¿ã³ãã¯è³ª+α
- â èªãã§ããããè¨äº
- â åèè«æ
Â
Â
â çèã®ä¸æ´»åã¯çã¿ã³ãã¯è³ªã®åææµææ§ãèªçºãã
Â
ãçèã®ãã¨ã§ããçã¿ã³ãã¯è³ªã¯24æéããã¤ãåæã¨å解ãç¹°ãè¿ãã¦ãã¾ããããç¨åº¦ã®èº«ä½æ´»åãè¡ãªã£ã¦ããå ´åãç©ºè ¹ã®ã¨ãã«å解ä½ç¨ã大ãããªããé£äºï¼ã¿ã³ãã¯è³ªï¼ãã¨ããã¨ã§åæä½ç¨ã大ãããªãã¾ãããã®ããã3é£ã®é£äºããã£ããã¨æåãããã¨ã«ãã£ã¦1æ¥ã®çã¿ã³ãã¯è³ªã®åæã¨å解ã®ãã©ã³ã¹ãã¨ããçèéãä¸å®ã«ä¿ãããã®ã§ãã
Fig.1ï¼Atherton PJ, 2016ããçè ä½æ
Â
ãçãã¬ãããã¨çã¿ã³ãã¯è³ªã®åææ度ãé«ã¾ããããã§ã¿ã³ãã¯è³ªãæåããã¨çã¿ã³ãã¯è³ªã®åæä½ç¨ãå¢å¤§ããå解ä½ç¨ã大ããä¸åããããçè¥å¤§ãçãã¾ãã
ãçãã¬å¾ã®ã¿ã³ãã¯è³ªã®æåã¯ã24æéããæèãã¹ãçç±ã
Â
ãã§ã¯ãã±ã¬ãªã©ã§èº«ä½ãåãããªãã¨ãã®çã¿ã³ãã¯è³ªã®åæã»å解ã®ãã©ã³ã¹ã¯ã©ã®ããã«ãªãã®ã§ããããï¼
Â
ã2008å¹´ãããã¯ãã¹ã¿ã¼å¤§å¦ã®ã°ãã¼ãã¼ãã¯ãçèã®ä¸æ´»åãçã¿ã³ãã¯è³ªã®åæä½ç¨ã«ä¸ããå½±é¿ã«ã¤ãã¦å ±åãã¦ãã¾ãã
Â
ã20代ã®ç·å¥³ã被é¨è ã¨ãã¦éããç足ãã®ãã¹ã§åºå®ããå¤§è ¿åé çã®çæ´»åãè¡ããªãããã«ãã¾ããããã®ç¶æ ã§14æ¥ééããããã¨ã両å´ã®å¤§è ¿åé çã®çã¿ã³ãã¯è³ªã®åæä½ç¨ãè¨æ¸¬ããã¾ããããã®çµæãåºå®ãã¦ããå´ã®å¤§è ¿åé çã®çæé¢ç©ã®æ¸å°ã¨ã¨ãã«ãã¿ã³ãã¯è³ªæåã«ããçã¿ã³ãã¯è³ªã®åæä½ç¨ã®å¢å¤§ãå°ãªããã¨ã示ãããã®ã§ãï¼Glover EI, 2008ï¼ã
Fig.2ï¼Glover EI, 2008ããçè ä½æ
Â
ããã®çµæãæ¯æããããã«ã2016å¹´ã«ã¯ãã¼ã¹ããªãã大å¦ã®ã¦ã©ã¼ã«ãã«ãã£ã¦ã5æ¥éã¨ããçæéã®çèã®ä¸æ´»åã§ããã¿ã³ãã¯è³ªã®æåã«ããçã¿ã³ãã¯è³ªã®åæä½ç¨ã®å¢å¤§ãæå¶ããããã¨ãå ±åããã¦ãã¾ãï¼Wall BT, 2016ï¼ã
Â
ããããã®å ±åã«ãããç¾å¨ã§ã¯çèã®ä¸æ´»åãããç¶æ³ã§ã¯ãã¿ã³ãã¯è³ªãæåãã¦ãçã¿ã³ãã¯è³ªã®åæä½ç¨ã®å¢å¤§ãæå¶ããããã¨ã示åããã¦ããããã®ãããªåæä½ç¨ã®æ¸å°ã¯ãåææµææ§ï¼anabolic resistanceï¼ãã¨å¼ã°ãã¦ãã¾ãï¼Cholewa JM, 2017ï¼ã
Â
ãã§ã¯ãçèã®ä¸æ´»åã¯çã¿ã³ãã¯è³ªã®å解ä½ç¨ã«ã©ã®ãããªå½±é¿ãä¸ããã®ã§ããããï¼
Â
ãä¸æ´»åãçã¿ã³ãã¯è³ªã®å解ä½ç¨ãå¢å¤§ãããå åã§ããFOXOãMuRF1ãªã©ãå¢å ããããã¨ã示åããã¦ãã¾ããã¾ããã¢ã¤ãªã¯å¤§å¦ã®ã¨ãã¼ããã¯ãçã¿ã³ãã¯è³ªã®å解ä½ç¨ã®ãã¼ã«ã¼ã¨ããã3-ã¡ãã«ãã¹ãã¸ã³ãããã3æ¥éã®çèã®ä¸æ´»åã«ãã£ã¦ä¸æãããã¨ãå ±åãã¦ãã¾ãï¼Ebert SM, 2010ï¼ã
Â
ããããã®å ±åãããçèã®ä¸æ´»åãçã¿ã³ãã¯è³ªã®å解ä½ç¨ãå¢å¤§ããããã¨ãæ¨æ¸¬ããã¾ãããå®éã«çã¿ã³ãã¯è³ªã®å解ä½ç¨ãè¨æ¸¬ããæ¹æ³ã確ç«ããã¦ããªããããç¾å¨ã¾ã§ã«ã³ã³ã»ã³ãµã¹ãå¾ããã¦ãã¾ããã
Â
ããããã®æ¤è¨¼çµæãããçèã®ä¸æ´»åã«ããçèéã®æ¸å°ã¯ãçã¿ã³ãã¯è³ªã®å解ä½ç¨ã®å¢å¤§ããããçã¿ã³ãã¯è³ªã®åæä½ç¨ãæ¸å°ããåææµææ§ã«ãã£ã¦èªçºãããã¨èãããã¦ãã¾ãï¼Atherton PJ, 2016ï¼ã
Fig.3ï¼Atherton PJ, 2016ããçè ä½æ
â çã¿ã³ãã¯è³ªã®åææµææ§ã®æ¹åã«ã¯ã¿ã³ãã¯è³ª+α
Â
ãçèã®ä¸æ´»åã«ããçèéã®æ¸å°ã¯ãã¿ã³ãã¯è³ªãæåãã¦ãå¹æçã«çã¿ã³ãã¯è³ªã®åæãçããªããåææµææ§ãã«èµ·å ãããã¨ã示åããã¦ãã¾ããçèéãç¶æããããã«ã¯ããã®åææµææ§ãæ¹åãã¦ãçã¿ã³ãã¯è³ªã®åæä½ç¨ãå¢å¤§ãããå¿ è¦ãããã¾ãã
Â
ãã§ã¯ãçã¿ã³ãã¯è³ªã®åææµææ§ãã©ã®ããã«å æããã°è¯ãã®ã§ããããï¼
Â
ããã®åãã«ãããµã¹å¤§å¦ã®ããã³ã¸ã§ã¼ã³ãºãã¯ã·ã³ãã«ã«çãã¾ãã
Â
ããé«å質ãªã¿ã³ãã¯è³ªãå¤ãæåããã°è¯ãã
Â
ã2004å¹´ãããã³ã¸ã§ã¼ã³ãºãã¯ã30代ã®ç·å¥³ã被é¨è ã¨ãã¦éãã28æ¥éãã®éããããä¸ã§å®éã«éããããã«æ示ãã¾ããã
Â
ã被é¨è ã¯å¿ é ã¢ããé ¸ï¼EAA16.5gï¼ãæåããã°ã«ã¼ãã¨æåããªãã°ã«ã¼ãã«åãããã28æ¥éã®å®éæéã®åå¾ã§çã¿ã³ãã¯è³ªã®åæãå解ã®ãã©ã³ã¹ãè¨æ¸¬ããã¾ããããã®çµæã28æ¥å¾ã«EAAãæåããã°ã«ã¼ãã¯çã¿ã³ãã¯è³ªã®åæä½ç¨ã®å¢å¤§ãèªããããçèéã®æ¸å°ãé²ããã¨ã示ãããã®ã§ãï¼Paddon-Jones D, 2004ï¼ã
Â
Fig.4ï¼Paddon-Jones D, 2004ããçè ä½æ
Â
ãã¾ã2016å¹´ãããã³ã¸ã§ã¼ã³ãºãã®çµæãæ¯æããããã«ãã¤ã³ã°ãªãã·ã¥ãã¯ã1é£ããã3ã4gã®ãã¤ã·ã³æåãçèã®ä¸æ´»åã«ããçã¿ã³ãã¯è³ªã®åææµææ§ãæ¹åããããã¨ãå ±åãã¦ãã¾ãï¼English KL, 2016ï¼ã
Â
ãããã¦ããããã®å ±åãã¾ã¨ããã¬ãã¥ã¼ã§ã¯ãå¿ é ã¢ããé ¸ããã¤ã·ã³ãè±å¯ã«å«ãã ãããã¤ã³ãé£äºã®æåãçèã®ä¸æ´»åã«ããçã¿ã³ãã¯è³ªã®åææµææ§ãæ¹åãããçèéã®ç¶æã«å¯ä¸ããã¨çµè«ã¥ãã¦ãã¾ãï¼Wall BT, 2013ãGalvan E, 2016ï¼ã
Â
ãããããä¸æ¹ã§ã¿ã³ãã¯è³ªã®æåãçã¿ã³ãã¯è³ªã®åææµææ§ãæ¹åããªãã¨ããå ±åãããã¾ãã
ã
ããªã¼ã¯ã©ã³ã大å¦ã®ãããã§ã«ãã¯ã50æ³åå¾ã®è¢«é¨è ã«å¯¾ãã¦14æ¥éã®å®éãæ示ãããããã¤ã³ï¼1.1g/kg/dï¼ã®æåã«ããçã¿ã³ãã¯è³ªã®åæä½ç¨ã¸ã®å½±é¿ã調æ»ãã¾ãããããããã¤ã³æåã«ããçã¿ã³ãã¯è³ªã®åæä½ç¨ã®å¢å¤§ã¯èªãããã¾ããã§ããï¼Mitchell CJ, 2017ï¼ã
Â
ãçèã®ä¸æ´»åã«ããçã¿ã³ãã¯è³ªã®åææµææ§ã«å¯¾ãã¦ãé«å質ãªã¿ã³ãã¯è³ªãæåãããã°è¯ããã¨ãã¦ãå¿ é ã¢ããé ¸ããã¤ã·ã³ãè±å¯ã«å«ãã¿ã³ãã¯è³ªã®æåãæ¨å¥¨ããã¦ãã¾ãããã話ã¯ããç°¡åã§ã¯ãªãããã§ãã
Â
ãçã¿ã³ãã¯è³ªã®åææµææ§ã«å¯¾ããã¿ã³ãã¯è³ªæåã«ã¤ãã¦ã®è°è«ã®ãªãã§ãã²ã¨ã¤ã®è¦è§£ã示ããã®ãã³ã¼ã¹ã¿ã«ã»ãã£ãã©ã¤ã大å¦ã®ã³ã¬ã¯ãã§ãã
Â
ãã³ã¬ã¯ãã¯ãçèã®ä¸æ´»åã«ããçã¿ã³ãã¯è³ªã®åææµææ§ã«å¯¾ãã¦ãã¤ã·ã³ãªã©ãè±å¯ã«å«ãã¿ã³ãã¯è³ªã®æåã¯æç¨ã§ããã¨ãã¤ã¤ãããè¨ãã¾ãã
Â
ããã¿ã³ãã¯è³ªã®æåã«ãã©ã¹ã¢ã«ãã¡ãå¿ è¦ã§ããã
Â
ã2017å¹´ãçèã®ä¸æ´»åãå é½¢ã«ããçèéã®æ¸å°ã«ã¤ãã¦ã®ã¬ãã¥ã¼ã§ãã³ã¬ã¯ãã¯ä¸æ´»åãå é½¢ã«ãããæ ¢æ§ççããçã¿ã³ãã¯è³ªã®åææµææ§ãå解ä½ç¨ã®å¢å¤§ã«å¯ä¸ããã¨è¿°ã¹ã¦ãã¾ãã
Â
ãæ ¢æ§ççã«ãã£ã¦çæãããççæ§ãµã¤ãã«ã¤ã³ã¯ãçã¿ã³ãã¯è³ªã®åæä½ç¨ãå¢å¤§ãããå åã§ããmTORã®æ´»åãæå¶ããå解ä½ç¨ãä¿ãã¦ãããã³ã»ãããã¢ã½ã¼ã çµè·¯ãæ´»æ§åããããã¨ã示åããã¦ãã¾ãï¼Xia Z, 2017ï¼ã
Â
ããã®ãããªæ ¢æ§ççãåå¨ããå ´åãçèã®ä¸æ´»åã«å¯¾ãã¦é«å質ãªã¿ã³ãã¯è³ªã®æåã ãã§ã¯ååã«çã¿ã³ãã¯è³ªã®åææµææ§ãæ¹åã§ããªãã¨ãã¦ãã¾ããããã¦ãå¹æçã«çã¿ã³ãã¯è³ªã®åææµææ§ãæ¹åããããã«ã¯ãã¿ã³ãã¯è³ªã®æåã«æé ¸åä½ç¨ããã¤æ é¤ç´ ã追å ãããã¨ãæå¹ã ããã¨æ¨å¯ãã¦ãã¾ãã
Â
ãå®éã«ãåç©å®é¨ã§ã¯çèã®ä¸æ´»åã®ã©ããã«å¯¾ãã¦ããã¤ã·ã³ã«æé ¸åä½ç¨ã®ãããã¿ãã³Aããã¿ãã³Eãªã©ãä»å ããã¨ããããã¤ã·ã³ã®ã¿ã«æ¯ã¹ã¦ææã«çã¿ã³ãã¯è³ªã®åæä½ç¨ãå¢å¤§ãããã¨ã示ããã¦ãã¾ãï¼Marzani B, 2008ï¼ã
Â
ãããããªããããããã®æ¨è«ã¯åç©å®é¨ã®çµæããã¨ã«ãã¦ãããããããã«ããã¿ã³ãã¯è³ªã®æåã¨æé ¸åä½ç¨ã®ããæ é¤ç´ ã«ããæ¤è¨¼ãå¿ è¦ã§ããã¨ãã¦ãã¾ãã
Â
ã
ãçèã®ä¸æ´»åã«ãçèéã®æ¸å°ã¯ãçã¿ã³ãã¯è³ªã®åææµææ§ã«èµ·å ãã¦ããã¨èãããã¦ãããããã«å¯¾ãã¦ãã¤ã·ã³ãªã©ãå«ãé«å質ãªã¿ã³ãã¯è³ªã®æåãæ¨å¥¨ããã¦ãã¾ãã
Â
ããããã®å ±åã¯ãã¬ã¼ãã³ã°çµé¨ã®ãªã被é¨è ã主ã§ããããã¬ã¼ãã³ã°çµé¨ã®ãã被é¨è ã«ããæ¤è¨¼ãå¿ è¦ã§ããããããªãããçã¿ã³ãã¯è³ªã®åæã»å解ä½ç¨ã®ä»çµã¿ã¯çµé¨ã®æç¡ã«é¢ãããåãã§ãããããå¿ç¨ã§ããå¯è½æ§ã¯ããã¨æããã¾ãã
Â
ãã¾ããçèã®ä¸æ´»åã«ããçèéã®æ¸å°ã«ã¯ãã³ã¬ã¯ãã示åããæ ¢æ§ççã®å½±é¿ãããã¾ã å®æ¸¬ã§ããªãçã¿ã³ãã¯è³ªã®å解ä½ç¨ã®å¢å¤§ã®å½±é¿ãèãããã¾ãããããã®ã¡ã«ããºã ãæ確ã«ãªãã°ããããªã対å¿çãæããã«ãªãã¾ããæ°ããªå ±åãããã¾ããããæ¬ããã°ã§ããç´¹ä»ããã¦ããã ãã¾ãã
Â
ãç¾æç¹ã§ã¯ãçèã®ä¸æ´»åã«ããçèéã®æ¸å°ã«å¯¾ããå¹æçãªäºé²æ³ã®ã¨ããã³ã¹ã¯ç¤ºããã¦ãã¾ããããã®ä¸ã§ãããã¤ã·ã³ãå¤ãå«ã赤身èãåµããããã¤ã³ããã®ã¿ã³ãã¯è³ªãæåãããã¨ãçèéã®æ¸å°ã軽æ¸ããããã¨ã示åããã¦ããã試ãã¦ã¿ã価å¤ã¯ããããã§ãã
Â
Â
çãã¬ã®éè¦ãªã¨ããã³ã¹ãã¾ã¨ããæ°åã§ãï¼
ç§å¦çã«æ£ããçã㬠æå¼·ã®æç§æ¸
- ä½è : 庵éæå°
- åºç社/ã¡ã¼ã«ã¼: KADOKAWA
- çºå£²æ¥: 2019/03/28
- ã¡ãã£ã¢: åè¡æ¬
- ãã®ååãå«ãããã°ãè¦ã
Â
Â
Â
Â
â èªãã§ããããè¨äº
ã·ãªã¼ãºâ ï¼çèãå¢ããããã®æ é¤æåã®ã¡ã«ããºã ãç解ããã
ã·ãªã¼ãºâ¡ï¼çãã¬ã®å¹æãæ大ã«ããã¿ã³ãã¯è³ªã®æåéãç¥ã£ã¦ããã
ã·ãªã¼ãºâ¢ï¼çãã¬ã®å¹æãæ大ã«ããã¿ã³ãã¯è³ªã®æåã¿ã¤ãã³ã°ãç¥ã£ã¦ããã
ã·ãªã¼ãºâ£ï¼çãã¬ã®å¹æãæ大ã«ããã¿ã³ãã¯è³ªã®æåãã¿ã¼ã³ãç¥ã£ã¦ããã
ã·ãªã¼ãºâ¤ï¼çãã¬ã®å¹æãæ大ã«ããå°±å¯åã®ãããã¤ã³æåãç¥ã£ã¦ããã
ã·ãªã¼ãºâ¥ï¼çãã¬ã®å¹æãæ大ã«ããå°±å¯åã®ãããã¤ã³æåã®æ¹æ³è«Â
ã·ãªã¼ãºâ¦ï¼çãã¬ã®å¹æãæ大ã«ããéå強度ï¼è² è·ï¼ã«ã¤ãã¦ç¥ã£ã¦ããã
ã·ãªã¼ãºâ§ï¼çãã¬ã®å¹æãæ大ã«ããéå強度ï¼è² è·ï¼ã®å®è·µè«
ã·ãªã¼ãºâ¨ï¼çãã¬ã®å¹æãæ大ã«ããã»ããæ°ã«ã¤ãã¦ç¥ã£ã¦ãããÂ
ã·ãªã¼ãºâ©ï¼çãã¬ã®å¹æãæ大ã«ããã»ããéã®ä¼æ©æéã«ã¤ãã¦ç¥ã£ã¦ããã
ã·ãªã¼ãºâªï¼çãã¬ã®å¹æãæ大ã«ãããã¬ã¼ãã³ã°ã®é »åº¦ã«ã¤ãã¦ç¥ã£ã¦ããã
ã·ãªã¼ãºâ«ï¼çãã¬ã®å¹æãæ大ã«ããã¿ã³ãã¯è³ªã®å質ã«ã¤ãã¦ç¥ã£ã¦ããã
ã·ãªã¼ãºâ¬ï¼çãã¬ã®å¹æãæ大ã«ãããã¤ã·ã³ã«ã¤ãã¦ç¥ã£ã¦ããã
ã·ãªã¼ãºâï¼çãã¬ã®å¹æãæ大ã«ããã¿ã³ãã¯è³ªã®æåæ¹æ³ã¾ã¨ã
ã·ãªã¼ãºâ®ï¼çãã¬ã®å¹æãæ大ã«ãããã¼ã¿ã¢ã©ãã³ã«ã¤ãã¦ç¥ã£ã¦ããã
ã·ãªã¼ãºâ¯ï¼ãã¤ã¾ã§ãè¥ã ããçèãç¶æããããã«ã¯çãã¬ã ãããä¸ååï¼
ã·ãªã¼ãºâ°ï¼çãã¬ã®å¹æãæ大ã«ããã»ããæ°ã«ã¤ãã¦ç¥ã£ã¦ãããï¼2017å¹´7æçï¼Â
ã·ãªã¼ãºâ±ï¼çãã¬ã¨ã¢ã«ã³ã¼ã«æåã®æ®é ·ãªçå®
ã·ãªã¼ãºâ²ï¼çãã¬ã®å¹æãæ大ã«ããã¿ã³ãã¯è³ªã®æåéãç¥ã£ã¦ãããï¼2017å¹´7æçï¼
ã·ãªã¼ãºâ³ï¼é·çãã®ç§è¨£ã¯çãã¬ã«ãã
ã·ãªã¼ãºãï¼çãã¬ã®æé©ãªè² è·éãç¥ã£ã¦ãããï¼2017å¹´8æçï¼
ã·ãªã¼ãºãï¼çãã¬ãä¸å®ã解æ¶ããã¨ããã³ã¹
ã·ãªã¼ãºãï¼çèéãç¶æããªãããã¤ã¨ããããæ¹æ³è«
ã·ãªã¼ãºãï¼ãããã¤ã³ã®æåã¯ãã¬ã¼ãã³ã°åã¨å¾ã®ã©ã¡ããå¹æçï¼
ã·ãªã¼ãºãï¼çãã¬ã®åã«ã¹ãã¬ããã³ã°ããã¦ã¯ãããªãçç±
ã·ãªã¼ãºãï¼çãã¬ã®å¹æãæ大ã«ããã¦ã©ã¼ã ã¢ããã®æ¹æ³ãç¥ã£ã¦ããã
ã·ãªã¼ãºãï¼çãã¬ã®å¹æãæ大ã«ããã»ããéã®ä¼æ©æéãç¥ã£ã¦ãããï¼2017å¹´9æçï¼
ã·ãªã¼ãºãï¼BCAAãçèçãå復ãããã¨ããã³ã¹
ã·ãªã¼ãºãï¼çãã¬ã®å¹æãæ大ã«ããã¿ãã´ã®æ£ããé£ã¹æ¹
ã·ãªã¼ãºãï¼çãã¬ãç¡ç ã®è³ªãé«ãããä¸çåã®ã¨ããã³ã¹ãæããã«
ã·ãªã¼ãºãï¼çèã®å¤§ããããçãã¬ããã¶ã¤ã³ããã
ã·ãªã¼ãºãï¼HMBãçãã¬ã®å¹æãé«ããçç±ï½å½éã¹ãã¼ãæ é¤å¦ä¼ã®ã¬ã¤ãã©ã¤ã³ããææ°ã®ã¨ããã³ã¹ã¾ã§
ã·ãªã¼ãºãï¼çãã¬ã®å¹æãé«ããææ°ã®3ã¤ã®èãæ¹ãSchoenfeldæ°ã®ã¤ã³ã¿ãã¥ã¼ãã
ã·ãªã¼ãºãï¼çãã¬ã«ãã£ã¦è³ãå¤ãããææ°ã®ã¡ã«ããºã ãæããã«
ã·ãªã¼ãºãï¼ãã¨ã¤ãããã¤ã³ã¯é£æ¬²ãæãããææ°ã®ã¨ããã³ã¹ãç¥ã£ã¦ããã
ã·ãªã¼ãºã±ï¼çãã¬ãç æ°ã«ããæ»äº¡çãæ¸å°ããã幸ç¦ãªçå®
ã·ãªã¼ãºã²ï¼ãããã¤ã³ã¯è èã«ãã¡ã¼ã¸ãä¸ããï¼ãç¾ä»£ã®ç§å¦ã示ãã²ã¨ã¤ã®çã
ã·ãªã¼ãºã³ï¼çãã¬ã¨ã¢ã«ã³ã¼ã«ã®æ®é ·ãªçå®ï¼ç¶ç·¨ï¼
ã·ãªã¼ãºã´ï¼çãã¬ã®å¹æãæ大ã«ãããé¢ç¯ãåããç¯å²ãã«ã¤ãã¦ç¥ã£ã¦ããã
ã·ãªã¼ãºãµï¼çãã¬ãç¶ããªãçç±ããã¼ãã¼ã大å¦ãæããã«ããçãã¨ã¯ï¼
ã·ãªã¼ãºã¶ï¼çãã¬ã¨éºä¼ã®æ¬å½ã®çå®ãçãã¬ã®å¹æã¯éºä¼ã§æ±ºã¾ãï¼
ã·ãªã¼ãºã·ï¼ã¨ããã³ã¹ã«ãã¨ã¥ãçè¥å¤§ãæ大åããããã®çãã¬ã»ã¬ã¤ãã©ã¤ã³
ã·ãªã¼ãºã¸ï¼çãã¬ãã¦ããã®çè¥å¤§ã¯æµ®è «ï¼ããã¿ï¼ã§ããã¨ããæ®å¿µãªçå®
ã·ãªã¼ãºã¹ï¼æéããªãã¨ãã«ããã¹ãçãã¬ã¡ãã¥ã¼ã¨ã¯ããã®ç§å¦çæ ¹æ ãããããã«
ã·ãªã¼ãºãºï¼çãã¬ã®å¹æãæ大ã«ããæ°ãããã¬ã¼ãã³ã°ããã°ã©ã ã®èãæ¹ãç¥ã£ã¦ããã
ã·ãªã¼ãºã»ï¼çãã¬ã¯å¿èãå¼·ããããææ°ã®ã¨ããã³ã¹ãæããã«
ã·ãªã¼ãºã¼ï¼ãããã¤ã³ã¯éª¨ããããããï¼ãææ°ã®ç 究çµæãç¥ã£ã¦ããã
ã·ãªã¼ãºã½ï¼ã³ã¼ãã¼ãçãã¬ã®ããã©ã¼ãã³ã¹ãé«ããããã®ç§å¦çæ ¹æ ãç¥ã£ã¦ããã
ã·ãªã¼ãºã¾ï¼ç¡ç ä¸è¶³ã¯çãã¬ã®å¹æãä½ä¸ãããï½ãã®ç§å¦çæ ¹æ ãç¥ã£ã¦ããã
ã·ãªã¼ãºã¿ï¼ã¤ã¡ã¼ã¸ãã¬ã¼ãã³ã°ãçãã¬ã®å¹æãé«ããããã®ç§å¦çæ ¹æ ãç¥ã£ã¦ããã
ã·ãªã¼ãº51ï¼çãã¬å¾ã®ã¢ã«ã³ã¼ã«æåãçåã®å復ã妨ããï¼ãææ°ã®ç 究çµæãç¥ã£ã¦ããã
ã·ãªã¼ãº52ï¼çãã¬å¾ã®ã¿ã³ãã¯è³ªã®æåã¯ã24æéããæèããã¹ãçç±
ã·ãªã¼ãº53ï¼çãã¬ãé«è¡å§ãæ¹åãããããã®ç§å¦çæ ¹æ ãç¥ã£ã¦ããã
ã·ãªã¼ãº54ï¼ã±ã¬ãªã©ã§çãã¬ã§ããªãã¨ãã»ã©ã¿ã³ãã¯è³ªãæåããã¹ããï¼
ã·ãªã¼ãº55ï¼çãã¬ã¯è³åä¸ã®çºçãªã¹ã¯ãé«ããã®ã?ãçãã¬ã«ãããªã¹ã¯ãç¥ã£ã¦ããã
ã·ãªã¼ãº56ï¼çãã¬ãç¶ããæè¡ãæå¿åãããã¸ã¡ã³ãããã
ã·ãªã¼ãº57ï¼çãã¬å¾ã«ãããã¤ã³ã飲ãã§ããã«ä»°åãã«å¯ã¦ã¯ãããªãçç±
ã·ãªã¼ãº58ï¼çãã¬ã¯æããã¹ãããå¤æ¹ããã¹ããåé¡
ã·ãªã¼ãº59ï¼çãã¬ã®å¹æãæ大ã«ããé£åããããã¤ã³ã®é¸ã¶ãã¤ã³ããç¥ã£ã¦ããã
ã·ãªã¼ãº60ï¼ãã³ããã¬ã¹ããããªã大è¸çæå·ã«ã¤ãã¦ç¥ã£ã¦ããã
ã·ãªã¼ãº61ï¼çãã¬ã®å¹æãæ大ã«ããã¿ã³ãã¯è³ªã®æåãã¿ã¼ã³ãç¥ã£ã¦ãããï¼2018å¹´4æçï¼
ã·ãªã¼ãº62ï¼çãã¬å¾ã®ã¿ã³ãã¯è³ªæåã«çæ°´åç©ï¼ç³è³ªï¼ã¯å¿ è¦ãªãï¼
ã·ãªã¼ãº63ï¼ãã¨ã¤ã»ãããã¤ã³ã¨çãã¬ããã¤ã¨ãããå¥åº·ã«ã¤ãã¦ã®ææ°ã®ã¨ããã³ã¹ã¾ã¨ã
ã·ãªã¼ãº64ï¼çãã¬ã®å¹æãæ大ã«ãããçä¹³ãã®é¸ã³æ¹ãç¥ã£ã¦ããã
ã·ãªã¼ãº65ï¼ãããããããã¤ã³ã®æåã¯çãã¬ã®å¹æãé«ããã®ãï¼
ã·ãªã¼ãº66ï¼çåãç°¡åã«ã¢ãããããæ¹æ³ï½çåã¨ç¥çµã®é¢ä¿ãç¥ã£ã¦ããã
ã·ãªã¼ãº67ï¼çåå¢å¼·ã¨çè¥å¤§ã®å¹æãæ大ã«ãããã¬ã¼ãã³ã°å¼·åº¦ã®ææ°ã¨ããã³ã¹
ã·ãªã¼ãº68ï¼çãã¬ã¯ç²å´å°æã¾ã§è¿½ãè¾¼ãã¹ããï¼ãææ°ã®ã¨ããã³ã¹ãç¥ã£ã¦ããã
ã·ãªã¼ãº69ï¼çãã¬ã§ç²å´å°æã¾ã§è¿½ãè¾¼ãã§ã¯ãããªãçç±ï¼çåå¢å¼·ç·¨ï¼
ã·ãªã¼ãº70ï¼çãã¬ã§çè¥å¤§ã®å¹æãæ大ã«ãããéåã®ã¹ãã¼ãããç¥ã£ã¦ããã
ã·ãªã¼ãº71ï¼çãã¬ã§çåå¢å¼·ã®å¹æãæ大ã«ãããéåã®ã¹ãã¼ãããç¥ã£ã¦ããã
ã·ãªã¼ãº72ï¼ãã¬ãã£ããã¬ã¼ãã³ã°ã¯çè¥å¤§ã«å¹æçãªã®ãï¼ãææ°ã¨ããã³ã¹ãç¥ã£ã¦ããã
ã·ãªã¼ãº73ï¼çãã¬ãç¶ããæè¡ããéãããããã°çãã¬ã¯ç¶ç¶ã§ããï¼
ã·ãªã¼ãº74ï¼ãããã¤ã³ã¯è èã«ãã¡ã¼ã¸ãä¸ããï¼ããã¼ãã¼ã大å¦ã®è¦è§£ã¨ææ°ã¨ããã³ã¹
ã·ãªã¼ãº75ï¼çãã¬ã«ããçè¥å¤§ã®å¹æã¯å¼·åº¦ãåæ°ãã»ããæ°ãåãããç·è² è·éã«ãã£ã¦æ±ºã¾ã
ã·ãªã¼ãº76ï¼çãã¬ã®å¹æãæ大ã«ããã¿ã³ãã¯è³ªã®æåæ¹æ³ã¾ã¨ãï¼2018å¹´8æçï¼
ã·ãªã¼ãº77ï¼çãã¬ã¨HMBã®ææ°ã¨ããã³ã¹ï¼2018å¹´8æçï¼ã
ã·ãªã¼ãº78ï¼çãã¬ã«ããçèçã«ãã£ã¨ãå¹æçãªã¢ãã¿ã¼ã±ã¢ã®ææ°ã¨ããã³ã¹
ã·ãªã¼ãº79ï¼çè¥å¤§ã®ã¡ã«ããºã ããçãã¬ããã¶ã¤ã³ããã
ã·ãªã¼ãº80ï¼çãã¬ã®å¹æãæ大ã«ããé±ã®é »åº¦ï¼é±ã«ä½åï¼ï¼ã®ææ°ã¨ããã³ã¹
ã·ãªã¼ãº81ï¼çãã¬å¾ã®ã¯ã¼ã«ãã¦ã³ã«å¹æãªãï¼ãææ°ã®ã¬ãã¥ã¼çµæãç¥ã£ã¦ããã
ã·ãªã¼ãº82ï¼çãã¬ã®ç·è² è·éã¨ç²å´ã®é¢ä¿ãããã¬ã¼ãã³ã°ããã¶ã¤ã³ããã
ã·ãªã¼ãº83ï¼çãã¬ã®ããã©ã¼ãã³ã¹ãæ大ã«ããã¯ã¬ã¢ãã³ã®ææ°ã¨ããã³ã¹
ã·ãªã¼ãº84ï¼çãã¬ã®ãã¨ã¯é¢¨éªãã²ãããããªãï¼ãææ°ã¨ããã³ã¹ã¨å¯¾å¦æ³
ã·ãªã¼ãº85ï¼çãã¬ã®ããã©ã¼ãã³ã¹ãæ大ã«ããã«ãã§ã¤ã³ã®ææ°ã¨ããã³ã¹
ã·ãªã¼ãº86ï¼çãã¬ã¨ã°ã«ã¿ãã³ã®ææ°ã¨ããã³ã¹
ã·ãªã¼ãº87ï¼çãã¬ã¨ã¢ã«ã®ãã³ã®ææ°ã¨ããã³ã¹
ã·ãªã¼ãº88ï¼çãã¬ã¨ã·ãã«ãªã³ã®ææ°ã¨ããã³ã¹
ã·ãªã¼ãº89ï¼çãã¬ãããªãç¥ã£ã¦ãããããµããªã¡ã³ãã®ææ°ã¨ããã³ã¹ã¾ã¨ã
ã·ãªã¼ãº90ï¼çãã¬ãããã¨ã¢ããæ¬å½ã®çç±
ã·ãªã¼ãº91ï¼é«ã¿ã³ãã¯è³ªã¯è èã«ãã¡ã¼ã¸ãä¸ããªããææ°ã¨ããã³ã¹ãæããã«
ã·ãªã¼ãº92ï¼çãã¬ãããªãç¥ã£ã¦ããããé£äºã®ããã³ããã¼ãã¼ãæµã®é£äºãã¬ã¼ã
ã·ãªã¼ãº93ï¼çãã¬ãç¶ããæè¡ããã·ã¥ããã»ãã¹ããæ»ç¥ããã
ã·ãªã¼ãº94ï¼ã¹ã¯ã¯ããã®ãã©ã¼ã ã®åºæ¬ãç¥ã£ã¦ããããã¹ã¯ã¯ããã®ç§å¦ãÂ
ã·ãªã¼ãº95ï¼ã¹ã¯ã¯ããã®ãã©ã¼ã ã«ãã£ã¦çèã®æ´»åãç°ãªãçç±
ã·ãªã¼ãº96ï¼ã¹ã¯ã¯ããã®å¹æãæ大ã«ããã¹ã¿ã³ã¹å¹ ã¨è¶³é¨ã®åããç¥ã£ã¦ããã
ã·ãªã¼ãº97ï¼ãã³ããã¬ã¹ã®ãã©ã¼ã ã®åºæ¬ãç¥ã£ã¦ãããããã³ããã¬ã¹ã®ç§å¦ã
ã·ãªã¼ãº98ï¼ããã¯ãã³ããã¬ã¹ãããããã«é²åãã¦ããããã³ããã¬ã¹ã®ç§å¦ã
ã·ãªã¼ãº99ï¼ããããªããã®ãã©ã¼ã ã®åºæ¬ãç¥ã£ã¦ããããããããªããã®ç§å¦ã
ã·ãªã¼ãº100ï¼ããããªããã®ãªããã£ã³ã°ã®åºæ¬ãç¥ã£ã¦ããããããããªããã®ç§å¦ã
ã·ãªã¼ãº101ï¼çãã¬ãç¶ããæè¡ï½è³ãããã¯ãããï¼
ã·ãªã¼ãº102ï¼è ç«ã¦ä¼ãã®åæ°ã¨æ¡åããå¿èç ã®ãªã¹ã¯ãç¥ããï¼
ã·ãªã¼ãº103ï¼çãã¬ã¯æããã¹ãããå¤æ¹ããã¹ããï¼ãææ°ã¨ããã³ã¹ãç¥ã£ã¦ããã
ã·ãªã¼ãº104ï¼çãã¬ã«ããçè¥å¤§ã®å¹æã¯ãé±ã®ãã¬ã¼ãã³ã°éãã§æ±ºã¾ãï¼ãææ°ã¨ããã³ã¹ã
Â
Â
Â
â åèè«æ
Wall BT, et al. Skeletal muscle atrophy during short-term disuse: implications for age-related sarcopenia. Ageing Res Rev. 2013 Sep;12(4):898-906.
Glover EI, et al. Immobilization induces anabolic resistance in human myofibrillar protein synthesis with low and high dose amino acid infusion. J Physiol. 2008 Dec 15;586(24):6049-61.
Wall BT, et al. Short-term muscle disuse lowers myofibrillar protein synthesis rates and induces anabolic resistance to protein ingestion. Am J Physiol Endocrinol Metab. 2016 Jan 15;310(2):E137-47.
Cholewa JM, et al. Dietary proteins and amino acids in the control of the muscle mass during immobilization and aging: role of the MPS response. Amino Acids. 2017 May;49(5):811-820.
Ebert SM, et al. The transcription factor ATF4 promotes skeletal myofiber atrophy during fasting. Mol Endocrinol. 2010 Apr;24(4):790-9.
Atherton PJ, et al. Control of skeletal muscle atrophy in response to disuse: clinical/preclinical contentions and fallacies of evidence. Am J Physiol Endocrinol Metab.
Paddon-Jones D, et al. Essential amino acid and carbohydrate supplementation ameliorates muscle protein loss in humans during 28 days bedrest. J Clin Endocrinol Metab. 2004 Sep;89(9):4351-8.
English KL, et al. Leucine partially protects muscle mass and function during bed rest in middle-aged adults. Am J Clin Nutr. 2016 Feb;103(2):465-73.
Wall BT, et al. Nutritional strategies to attenuate muscle disuse atrophy. Nutr Rev. 2013 Apr;71(4):195-208.
Galvan E, et al. Protecting Skeletal Muscle with Protein and Amino Acid during Periods of Disuse. Nutrients. 2016 Jul 1;8(7).
Mitchell CJ, et al. The impact of dairy protein during limb immobilization and recovery on muscle size and protein synthesis; a randomized controlled trial. J Appl Physiol (1985). 2017 Nov 9:jap008032017.
Cholewa JM, et al. Dietary proteins and amino acids in the control of the muscle mass during immobilization and aging: role of the MPS response. Amino Acids. 2017 May;49(5):811-820. Â
Xia Z, et al. Targeting Inflammation and Downstream Protein Metabolism in Sarcopenia: A Brief Up-Dated Description of Concurrent Exercise and Leucine-Based Multimodal Intervention. Front Physiol. 2017 Jun 22;8:434.
Marzani B, et al. Antioxidant supplementation restores defective leucine stimulation of protein synthesis in skeletal muscle from old rats. J Nutr. 2008 Nov;138(11):2205-11.
Â